These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 33159234)

  • 21. Medulloblastoma in the age of molecular subgroups: a review.
    Juraschka K; Taylor MD
    J Neurosurg Pediatr; 2019 Oct; 24(4):353-363. PubMed ID: 31574483
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medulloblastoma: From Myth to Molecular.
    Ramaswamy V; Taylor MD
    J Clin Oncol; 2017 Jul; 35(21):2355-2363. PubMed ID: 28640708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current treatment of medulloblastoma: recent advances and future challenges.
    Rood BR; Macdonald TJ; Packer RJ
    Semin Oncol; 2004 Oct; 31(5):666-75. PubMed ID: 15497120
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updates on Management of Adult Medulloblastoma.
    Majd N; Penas-Prado M
    Curr Treat Options Oncol; 2019 Jun; 20(8):64. PubMed ID: 31236711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.
    Ramaswamy V; Remke M; Bouffet E; Bailey S; Clifford SC; Doz F; Kool M; Dufour C; Vassal G; Milde T; Witt O; von Hoff K; Pietsch T; Northcott PA; Gajjar A; Robinson GW; Padovani L; André N; Massimino M; Pizer B; Packer R; Rutkowski S; Pfister SM; Taylor MD; Pomeroy SL
    Acta Neuropathol; 2016 Jun; 131(6):821-31. PubMed ID: 27040285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intellectual Outcome in Molecular Subgroups of Medulloblastoma.
    Moxon-Emre I; Taylor MD; Bouffet E; Hardy K; Campen CJ; Malkin D; Hawkins C; Laperriere N; Ramaswamy V; Bartels U; Scantlebury N; Janzen L; Law N; Walsh KS; Mabbott DJ
    J Clin Oncol; 2016 Dec; 34(34):4161-4170. PubMed ID: 27507873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI features as a helpful tool to predict the molecular subgroups of medulloblastoma: state of the art.
    Colafati GS; Voicu IP; Carducci C; Miele E; Carai A; Di Loreto S; Marrazzo A; Cacchione A; Cecinati V; Tornesello A; Mastronuzzi A
    Ther Adv Neurol Disord; 2018; 11():1756286418775375. PubMed ID: 29977341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Approach to molecular subgrouping of medulloblastomas: Comparison of NanoString nCounter assay versus combination of immunohistochemistry and fluorescence in-situ hybridization in resource constrained centres.
    Kaur K; Jha P; Pathak P; Suri V; Sharma MC; Garg A; Suri A; Sarkar C
    J Neurooncol; 2019 Jul; 143(3):393-403. PubMed ID: 31104222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exclusive Hyperfractionated Radiation Therapy and Reduced Boost Volume for Standard-Risk Medulloblastoma: Pooled Analysis of the 2 French Multicentric Studies MSFOP98 and MSFOP 2007 and Correlation With Molecular Subgroups.
    Carrie C; Kieffer V; Figarella-Branger D; Masliah-Planchon J; Bolle S; Bernier V; Laprie A; Supiot S; Leseur J; Habrand JL; Alapetite C; Kerr C; Dufour C; Claude L; Chapet S; Huchet A; Bondiau PY; Escande A; Truc G; Nguyen TD; Pasteuris C; Vigneron C; Muracciole X; Bourdeaut F; Appay R; Dubray B; Colin C; Ferlay C; Dussart S; Chabaud S; Padovani L; ;
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1204-1217. PubMed ID: 32768563
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular subgrouping and characterization analysis of medulloblastomas in a cohort of Japanese patients].
    Wataya T; Hamasaki M; Taylor MD
    No Shinkei Geka; 2015 Feb; 43(2):117-25. PubMed ID: 25672552
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are molecular subgroups of medulloblastomas really prognostic?
    Frappaz D; Faure-Conter C; Meyronet D; Levard-Bonneville A; Beuriat PA; Sunyach MP; Barritault M
    Curr Opin Neurol; 2018 Dec; 31(6):747-751. PubMed ID: 30300240
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic profiling of medulloblastoma reveals novel proteins differentially expressed within each molecular subgroup.
    Narayan V; Jaiswal J; Sugur H; Sd S; Rao S; Chatterjee A; Gowda H; A A; Somanna S; Santosh V
    Clin Neurol Neurosurg; 2020 Sep; 196():106028. PubMed ID: 32580068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insights into cerebellar development and medulloblastoma.
    Bihannic L; Ayrault O
    Bull Cancer; 2016 Jan; 103(1):30-40. PubMed ID: 26688373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second-generation molecular subgrouping of medulloblastoma: an international meta-analysis of Group 3 and Group 4 subtypes.
    Sharma T; Schwalbe EC; Williamson D; Sill M; Hovestadt V; Mynarek M; Rutkowski S; Robinson GW; Gajjar A; Cavalli F; Ramaswamy V; Taylor MD; Lindsey JC; Hill RM; Jäger N; Korshunov A; Hicks D; Bailey S; Kool M; Chavez L; Northcott PA; Pfister SM; Clifford SC
    Acta Neuropathol; 2019 Aug; 138(2):309-326. PubMed ID: 31076851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.
    Łastowska M; Trubicka J; Niemira M; Paczkowska-Abdulsalam M; Karkucińska-Więckowska A; Kaleta M; Drogosiewicz M; Perek-Polnik M; Krętowski A; Cukrowska B; Grajkowska W; Dembowska-Bagińska B; Matyja E
    J Neurooncol; 2018 Jun; 138(2):231-240. PubMed ID: 29427151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
    Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
    J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Singular Value Decomposition-Based Penalized Multinomial Regression for Classifying Imbalanced Medulloblastoma Subgroups Using Methylation Data.
    Mohammed I; Elbashir MK; Faggad AS
    J Comput Biol; 2024 May; 31(5):458-471. PubMed ID: 38752890
    [No Abstract]   [Full Text] [Related]  

  • 38. Implications of tumor location on subtypes of medulloblastoma.
    Teo WY; Shen J; Su JM; Yu A; Wang J; Chow WY; Li X; Jones J; Dauser R; Whitehead W; Adesina AM; Chintagumpala M; Man TK; Lau CC
    Pediatr Blood Cancer; 2013 Sep; 60(9):1408-10. PubMed ID: 23512859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Subgroup-specific genomic alterations and potential prognostic biomarkers in childhood medulloblastomas].
    Menyhárt O; Szabó A; Garami M; Gyõrffy B
    Magy Onkol; 2019 Dec; 63(4):331-345. PubMed ID: 31821388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease.
    Ellison DW
    Acta Neuropathol; 2010 Sep; 120(3):305-16. PubMed ID: 20652577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.